Related Experiment Video
Updated: May 12, 2025

06:09
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
1.0K
Strain elastography for detecting advanced Fontan-associated liver disease: a retrospective study
Koji Imoto1, Takeshi Goya1, Yuki Azuma1
1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences , Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
BMC Gastroenterology
|May 7, 2025
Summary
This study shows that a two-step approach using platelet counts and the Liver Fibrosis Index (LFI) can accurately detect advanced Fontan-associated liver disease (aFALD). Early detection of aFALD improves patient prognosis.
Area of Science:
- Hepatology
- Cardiology
- Medical Diagnostics
Background:
- The Fontan procedure improves single ventricle heart defect outcomes but can lead to Fontan-associated liver disease (FALD).
- Advanced FALD (aFALD) signifies portal hypertension and carries a poor prognosis.
- Noninvasive tests (NITs) show promise for assessing liver fibrosis in FALD, with limited evaluation of the SE-derived Liver Fibrosis Index (LFI).
Purpose of the Study:
- To evaluate the efficacy of NITs, particularly LFI, in discriminating aFALD.
- To assess the diagnostic performance of LFI compared to other noninvasive markers.
Main Methods:
- A retrospective study of 46 Japanese patients with FALD, categorized into aFALD and non-aFALD groups.
- Analysis of platelet count, FIB-4 index, Forns index, and LFI for diagnostic accuracy.
- Evaluation of Shear Wave Elastography (SWE) and its derived parameters.
Main Results:
- Platelet count, FIB-4, Forns index, and LFI significantly differed between aFALD and non-aFALD groups.
- A platelet count cut-off of 185 × 10^3/μL showed high specificity for aFALD.
- In patients with higher platelet counts, an LFI cut-off of 2.21 demonstrated 100% sensitivity for aFALD.
Conclusions:
- A two-step diagnostic strategy combining platelet count and LFI accurately identifies aFALD.
- Early detection and intervention for aFALD are crucial for improving patient outcomes.
- LFI shows potential as a valuable noninvasive tool for managing FALD.

